VICO.ST STO
Vicore Pharma Holding AB (publ)
1W: -2.9%
1M: -14.5%
3M: -40.6%
YTD: -14.2%
1Y: -14.3%
3Y: -37.4%
5Y: -53.5%
kr 9.32 ($0.93)
-0.09 (-0.96%)
Weekly Expected Move ±5.1%
kr 8
kr 9
kr 9
kr 10
kr 10
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$374M
-127.0% ▼
Capital Expenditures
$374M
+0.0% ▲
5Y CAGR: +162.6%
Free Cash Flow
$0
+100.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$578M
-170.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$295M | -$291M | -$311M | -$194M | -$477M |
| Depreciation & Amort. | $4M | $4M | $3M | $2M | $0 |
| Stock-Based Comp. | -$2M | $5M | $0 | $0 | $0 |
| Change in Working Capital | $27M | -$21M | -$11M | -$2M | $42M |
| Other Non-Cash Items | -$1M | $8M | $69M | $29M | $61M |
| Operating Cash Flow | -$265M | -$300M | -$250M | -$165M | -$374M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$3M | $0 | -$65M | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$77M | $0 | -$199M | $0 | -$981M |
| Investment Sales | $70M | $77M | $55M | $214M | $382M |
| Other Investing | -$7K | $74K | $0 | $0 | -$2M |
| Investing Cash Flow | -$7M | $74M | -$144M | $149M | -$602M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$18M | -$13M | -$30M | -$48M | $0 |
| Financing Cash Flow | $318M | $187M | $471M | $834M | $431M |
| Net Change in Cash | $46M | -$37M | $77M | $822M | -$578M |
| Cash End of Period | $294M | $257M | $334M | $1.2B | $578M |
| Free Cash Flow | -$265M | -$303M | -$449M | -$165M | $0 |